Francesco Panzuto


Titolo Pubblicato in Anno
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database ENDOCRINE 2024
Endoscopic management of gastric, duodenal and rectal NETs: Position paper from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Society of Gastroenterology (SIGE), Italian Society of Digestive Endoscopy (SIED) DIGESTIVE AND LIVER DISEASE 2024
Type 3 gastric neuroendocrine neoplasms: the rising promise of conservative endoscopic management FRONTIERS IN MEDICINE 2024
Diagnostic and Therapeutic Management of Primary Orbital Neuroendocrine Tumors (NETs): Systematic Literature Review and Clinical Case Presentation BIOMEDICINES 2024
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size. a retrospective, Europe-wide, pooled cohort study THE LANCET ONCOLOGY 2023
Targeting neuroendocrine tumors with octreotide and lanreotide: Key points for clinical practice from NET specialists CANCER TREATMENT REVIEWS 2023
Management of functional pancreatic neuroendocrine neoplasms CURRENT TREATMENT OPTIONS IN ONCOLOGY 2023
European Neuroendocrine Tumor Society (ENETS) 2023 Guidance Paper for Gastroduodenal NET G1‐G3 JOURNAL OF NEUROENDOCRINOLOGY 2023
Utility of histopathological revision in the management of gastro-entero-pancreatic neuroendocrine neoplasia ENDOCRINE 2023
Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastro entero pancreatic neuroendocrine tumors: alternatives to RECIST JOURNAL OF NEUROENDOCRINOLOGY 2023
Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma DIGESTIVE AND LIVER DISEASE 2023
When Should We Adopt EUS-Guided Radiofrequency Ablation in Pancreatic Neuroendocrine Tumors? JOURNAL OF CLINICAL MEDICINE 2023
The meaning of R1 resection after endoscopic removal of gastric, duodenal and rectal neuroendocrine tumors EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY 2023
Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial BMC CANCER 2023
Outcomes of a 3-year prospective surveillance in individuals at high-risk for pancreatic cancer THE AMERICAN JOURNAL OF GASTROENTEROLOGY 2023
Thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker? ENDOCRINE 2023
Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group ADVANCES IN THERAPY 2023
Comparison of clinicopathological features and survival analysis between esophageal neuroendocrine carcinoma and esophageal squamous cell carcinoma based on the SEER database, alongside nomogram analysis for esophageal neuroendocrine carcinoma JOURNAL OF GASTROINTESTINAL ONCOLOGY 2023
Necrolytic Migratory Erythema Impact on Prognosis and Diagnosis of Glucagonoma: A Case Report HSOA JOURNAL OF CLINICAL STUDIES & MEDICAL CASE REPORTS 2023
Role of [18F]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors ENDOCRINE 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma